International journal of audiology · 2025
A clinical and real-world investigation of cochlear implant recipient speech performance in noise with the automation of ForwardFocus.
Clinical StudyСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nel Esti, Hong Wei, Playford Jakson, Mashal Marjan Emjay
Аннотация
OBJECTIVE: This study investigated the speech performance with and user acceptance of the Cochlear™ Nucleus® 8 Sound Processor, with a particular focus on the automatic activation of the noise reduction feature, ForwardFocus (FF), in the new SCAN 2 program (SCAN 2 FF).
DESIGN: Prospective, single-site, open-label within subject interventional study (NCT05080283).
STUDY SAMPLE: Twenty adult (>18 years of age) cochlear implant recipients with at least 6 months of experience with their cochlear implant system.
RESULTS: There was a significant and clinically meaningful decrease (improvement) in SRT of 4.3 and 4.2 dB with the SCAN 2 FF program compared to the SCAN 2 program in the S0Nrearhalf and S0N3 configurations, respectively (both p < 0.001). Scores on the Speech Spatial and Qualities of Hearing Scale (SSQ12) were comparable between the Nucleus 7 and Nucleus 8 Sound Processors. Most participants provided positive subjective evaluations of the SCAN 2 FF program and the overall Nucleus 8 Sound Processor following take-home use.
CONCLUSION: The SCAN 2 FF program on the Nucleus 8 Sound Processor offers cochlear implant recipients a clinically meaningful benefit for speech recognition in noise.
DESIGN: Prospective, single-site, open-label within subject interventional study (NCT05080283).
STUDY SAMPLE: Twenty adult (>18 years of age) cochlear implant recipients with at least 6 months of experience with their cochlear implant system.
RESULTS: There was a significant and clinically meaningful decrease (improvement) in SRT of 4.3 and 4.2 dB with the SCAN 2 FF program compared to the SCAN 2 program in the S0Nrearhalf and S0N3 configurations, respectively (both p < 0.001). Scores on the Speech Spatial and Qualities of Hearing Scale (SSQ12) were comparable between the Nucleus 7 and Nucleus 8 Sound Processors. Most participants provided positive subjective evaluations of the SCAN 2 FF program and the overall Nucleus 8 Sound Processor following take-home use.
CONCLUSION: The SCAN 2 FF program on the Nucleus 8 Sound Processor offers cochlear implant recipients a clinically meaningful benefit for speech recognition in noise.